Eric J. Brown

26.9k total citations · 6 hit papers
205 papers, 20.0k citations indexed

About

Eric J. Brown is a scholar working on Molecular Biology, Immunology and Immunology and Allergy. According to data from OpenAlex, Eric J. Brown has authored 205 papers receiving a total of 20.0k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Molecular Biology, 75 papers in Immunology and 70 papers in Immunology and Allergy. Recurrent topics in Eric J. Brown's work include Cell Adhesion Molecules Research (69 papers), DNA Repair Mechanisms (30 papers) and Phagocytosis and Immune Regulation (27 papers). Eric J. Brown is often cited by papers focused on Cell Adhesion Molecules Research (69 papers), DNA Repair Mechanisms (30 papers) and Phagocytosis and Immune Regulation (27 papers). Eric J. Brown collaborates with scholars based in United States, France and Germany. Eric J. Brown's co-authors include David Baltimore, Frederik P. Lindberg, Hattie D. Gresham, David H. Raulet, Sandra Oršulić, Stephan Gasser, Jie Chen, Timothy L. Ratliff, Mingjie Zhou and Scott D. Blystone and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Eric J. Brown

202 papers receiving 19.6k citations

Hit Papers

The DNA damage pathway regulates innate immune system lig... 1995 2026 2005 2015 2005 2000 2001 1995 2007 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
    2005 1.0k citations Eric J. Brown et al. profile →
  2. ATR disruption leads to chromosomal fragmentation and early embryonic lethality
    2000 765 citations Eric J. Brown et al. profile →
  3. Integrin-associated protein (CD47) and its ligands
    2001 716 citations Eric J. Brown profile →
  4. Control of p70 S6 kinase by kinase activity of FRAP in vivo
    1995 615 citations Eric J. Brown et al. profile →
  5. Deletion of the Developmentally Essential Gene ATR in Adult Mice Leads to Age-Related Phenotypes and Stem Cell Loss
    2007 588 citations Yaroslava Ruzankina, Carolina Pinzon‐Guzman et al. Cell stem cell profile →
  6. Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2)
    2022 91 citations Eric J. Brown et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric J. Brown United States 80 9.2k 7.3k 3.5k 3.4k 2.3k 205 20.0k
Victor L. J. Tybulewicz United Kingdom 75 9.4k 1.0× 10.0k 1.4× 3.2k 0.9× 2.3k 0.7× 1.7k 0.7× 201 22.7k
Clifford A. Lowell United States 85 6.5k 0.7× 11.8k 1.6× 2.7k 0.8× 4.1k 1.2× 1.9k 0.8× 227 20.7k
Carlos Martı́nez-A Spain 81 8.6k 0.9× 9.4k 1.3× 5.3k 1.5× 2.1k 0.6× 1.6k 0.7× 331 20.5k
Masayuki Miyasaka Japan 78 6.0k 0.7× 8.8k 1.2× 2.6k 0.7× 4.2k 1.2× 1.8k 0.8× 370 19.3k
Minoru Fukuda Japan 81 13.8k 1.5× 6.7k 0.9× 2.7k 0.8× 1.9k 0.5× 1.9k 0.8× 547 22.1k
John H. Kehrl United States 78 10.8k 1.2× 7.9k 1.1× 3.1k 0.9× 1.4k 0.4× 1.2k 0.5× 232 23.2k
Takashi Saito Japan 89 10.8k 1.2× 15.6k 2.1× 5.1k 1.5× 1.8k 0.5× 2.3k 1.0× 416 30.1k
Nancy Hogg United Kingdom 79 7.2k 0.8× 11.3k 1.5× 2.4k 0.7× 7.2k 2.1× 1.4k 0.6× 200 21.0k
J. Fernando Bazán United States 58 8.1k 0.9× 10.5k 1.4× 4.8k 1.4× 1.1k 0.3× 1.6k 0.7× 95 22.1k
Adrian J. Thrasher United Kingdom 77 11.9k 1.3× 5.7k 0.8× 4.1k 1.2× 2.0k 0.6× 1.2k 0.5× 401 21.8k

Countries citing papers authored by Eric J. Brown

Since Specialization
Citations

This map shows the geographic impact of Eric J. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric J. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric J. Brown more than expected).

Fields of papers citing papers by Eric J. Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric J. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric J. Brown. The network helps show where Eric J. Brown may publish in the future.

Co-authorship network of co-authors of Eric J. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Eric J. Brown. A scholar is included among the top collaborators of Eric J. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric J. Brown. Eric J. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marx, Christian, Xiaobing Qing, Yamin Gong, et al.. (2025). DNA damage response regulator ATR licenses PINK1-mediated mitophagy. Nucleic Acids Research. 53(5). 1 indexed citations
2.
Gitto, Sarah B., Gareth Davies, Sushil Kumar, et al.. (2023). A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression. Clinical Cancer Research. 30(8). 1567–1581. 16 indexed citations
3.
Wethington, Stephanie L., Payal D. Shah, Lainie P. Martin, et al.. (2023). C ombination A TR (ceralasertib) and P A R P (olaparib) I nhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer. Clinical Cancer Research. 29(15). 2800–2807. 40 indexed citations
4.
5.
Schaible, Bettina, Eric J. Brown, Carsten C. Scholz, et al.. (2019). Hydroxylase Inhibition Selectively Induces Cell Death in Monocytes. The Journal of Immunology. 202(5). 1521–1530. 7 indexed citations
6.
Brown, Eric J. & Cormac T. Taylor. (2017). Hypoxia‐sensitive pathways in intestinal inflammation. The Journal of Physiology. 596(15). 2985–2989. 35 indexed citations
7.
Kim, Hyoung, Erin George, Ryan L. Ragland, et al.. (2016). Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in BRCA -Mutant Ovarian Cancer Models. Clinical Cancer Research. 23(12). 3097–3108. 234 indexed citations
8.
Diep, Binh An, Qui Phung, Shailesh V. Date, et al.. (2013). Identifying Potential Therapeutic Targets of Methicillin-resistant Staphylococcus aureus Through in Vivo Proteomic Analysis. The Journal of Infectious Diseases. 209(10). 1533–1541. 35 indexed citations
9.
Gilad, Oren, Barzin Y. Nabet, Ryan L. Ragland, et al.. (2010). Combining ATR Suppression with Oncogenic Ras Synergistically Increases Genomic Instability, Causing Synthetic Lethality or Tumorigenesis in a Dosage-Dependent Manner. Cancer Research. 70(23). 9693–9702. 173 indexed citations
10.
Su, Xiao, Mette L. Johansen, Mark R. Looney, Eric J. Brown, & Michael A. Matthay. (2008). CD47 Deficiency Protects Mice from Lipopolysaccharide-Induced Acute Lung Injury and Escherichia coli Pneumonia. The Journal of Immunology. 180(10). 6947–6953. 53 indexed citations
11.
Ruzankina, Yaroslava, Carolina Pinzon‐Guzman, Amma Asare, et al.. (2007). Deletion of the Developmentally Essential Gene ATR in Adult Mice Leads to Age-Related Phenotypes and Stem Cell Loss. Cell stem cell. 1(1). 113–126. 588 indexed citations breakdown →
12.
García-García, Erick, Eric J. Brown, & Carlos Rosales. (2007). Transmembrane Mutations to FcγRIIA Alter Its Association with Lipid Rafts: Implications for Receptor Signaling. The Journal of Immunology. 178(5). 3048–3058. 48 indexed citations
13.
Lamy, Laurence, Arnaud Foussat, Eric J. Brown, et al.. (2007). Interactions between CD47 and Thrombospondin Reduce Inflammation. The Journal of Immunology. 178(9). 5930–5939. 128 indexed citations
14.
Yan, Jizhou, Karen Keeshan, Anthony Tubbs, et al.. (2006). The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression. Proceedings of the National Academy of Sciences. 103(4). 1018–1023. 139 indexed citations
15.
Capo, Christian, Yves Collette, Daniel Olive, et al.. (2003). Coxiella burnetii Avoids Macrophage Phagocytosis by Interfering with Spatial Distribution of Complement Receptor 3. The Journal of Immunology. 170(8). 4217–4225. 33 indexed citations
16.
Latour, Sylvain, Hiroyuki Tanaka, Christian E. Demeure, et al.. (2001). Bidirectional Negative Regulation of Human T and Dendritic Cells by CD47 and Its Cognate Receptor Signal-Regulator Protein-α: Down-Regulation of IL-12 Responsiveness and Inhibition of Dendritic Cell Activation. The Journal of Immunology. 167(5). 2547–2554. 199 indexed citations
17.
Capo, Christian, Frederik P. Lindberg, Sonia Meconi, et al.. (1999). Subversion of Monocyte Functions by Coxiella burnetii: Impairment of the Cross-Talk Between αvβ3 Integrin and CR3. The Journal of Immunology. 163(11). 6078–6085. 97 indexed citations
18.
Neff, Sherry, Elizabeth Rieder, Peter W. Mason, et al.. (1998). Foot-and-Mouth Disease Virus Virulent for Cattle Utilizes the Integrin α v β 3 as Its Receptor. Journal of Virology. 72(5). 3587–3594. 186 indexed citations
19.
Aslanzadeh, Jaber, et al.. (1989). Characterization of Soluble Fibronectin Binding to Bacille Calmette-Guerin. Microbiology. 135(10). 2735–2741. 25 indexed citations
20.
Godfrey, Henry P., et al.. (1989). Relationship of human macrophage agglutination factor to other fibronectins.. PubMed Central. 67(3). 321–7. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victor L. J. Tybulewicz Breakdown of academic impact, for papers by Clifford A. Lowell Breakdown of academic impact, for papers by Carlos Martı́nez-A Breakdown of academic impact, for papers by Masayuki Miyasaka Breakdown of academic impact, for papers by Minoru Fukuda Breakdown of academic impact, for papers by John H. Kehrl Breakdown of academic impact, for papers by Takashi Saito Breakdown of academic impact, for papers by Nancy Hogg Breakdown of academic impact, for papers by J. Fernando Bazán Breakdown of academic impact, for papers by Adrian J. Thrasher
Rankless by CCL
2026